首页 | 本学科首页   官方微博 | 高级检索  
     

舒利迭(50/500)对稳定期中重度COPD患者疗效观察
引用本文:吴德忠,钱震东. 舒利迭(50/500)对稳定期中重度COPD患者疗效观察[J]. 临床肺科杂志, 2009, 14(3): 288-289
作者姓名:吴德忠  钱震东
作者单位:铜陵有色职工总医院呼吸内科,安徽,244000
摘    要:目的观察舒利迭(50/500)对稳定期中重度慢性阻塞性肺疾病(COPD)的疗效。方法将80例经住院治疗处于稳定期中重度COPD患者,随机分为治疗组和对照组。对照组给予常规治疗,治疗组在此基础上给予吸入舒利迭(50/500)。记录治疗前和治疗后的肺功能和血气分析等指标。结果治疗组的总有效率显著高于对照组,两组疗效比较差异有显著性(P〈0.01),吸入舒利迭无明显的毒副作用。结论应用舒利迭(50/500)治疗稳定期中重度COPD,能显著改善动脉血气指标,使用安全,值得在临床上推广。

关 键 词:舒利迭(50/500)  中重度慢性阻塞性肺疾病  稳定期  疗效

The efficacy of seretide (50/500) in patients with stable moderate and severe chronic obstructive pulmonary disease
Wu De-zhong,Qian Zhen-dong. The efficacy of seretide (50/500) in patients with stable moderate and severe chronic obstructive pulmonary disease[J]. Journal of Clinical Pulmonary Medicine, 2009, 14(3): 288-289
Authors:Wu De-zhong  Qian Zhen-dong
Affiliation:.( Department of Respiratory Medicine, Anhui Tnagling Red Cross Hospital, ( Tongling Nonferrous Metals (Croup) Company employees General Hospital), Anhui Province, Tongling 244000, China)
Abstract:Objective To investigate the effects of treatment using seretide on patients with stable moderate and sever chronic obstructive pulmonary disease.Methods 80 patients with stable moderate and severe COPD after hospital discharge were randomly divided into treatment and control groups.The control group was given conventional treatment,the treatment group was given seretide(50/500)on the basis of conventional treatment.The parameters of lung function test and arterial blood gases were measured before and after...
Keywords:seretide (50/500)  moderate and severe chronic obstructive pulmonary disease  stable  effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号